American Century Companies’s Aerie Pharmaceuticals AERI Stock Holding History

American Century Companies’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-144,877	Closed	-$3.5M	–	1755
2019 Q4	$3.5M	Buy	144,877 +29,157	+25%	+$604K	﹤0.01%	858
2019 Q3	$2.22M	Buy	115,720 +6,985	+6%	+$160K	﹤0.01%	954
2019 Q2	$3.21M	Buy	108,735 +24,720	+29%	+$952K	﹤0.01%	928
2019 Q1	$3.99M	Sell	84,015 -5,414	-6%	-$238K	﹤0.01%	862
2018 Q4	$3.23M	Buy	89,429 +15,472	+21%	+$726K	﹤0.01%	897
2018 Q3	$4.55M	Buy	73,957 +1,900	+3%	+$122K	﹤0.01%	875
2018 Q2	$4.87M	Buy	72,057 +15,718	+28%	+$879K	﹤0.01%	855
2018 Q1	$3.06M	Buy	56,339 +22,751	+68%	+$1.27M	﹤0.01%	931
2017 Q4	$2.01M	Buy	33,588 +9,352	+39%	+$567K	﹤0.01%	1011
2017 Q3	$1.18M	Buy	24,236 +228	+0.9%	+$12.4K	﹤0.01%	1119
2017 Q2	$1.26M	Sell	24,008 -23,111	-49%	-$1.08M	﹤0.01%	1107
2017 Q1	$2.14M	Sell	47,119 -195	-0.4%	-$8.7K	﹤0.01%	1030
2016 Q4	$1.79M	Sell	47,314 -2,892	-6%	-$109K	﹤0.01%	1059
2016 Q3	$1.9M	Buy	+50,206	New	+$1.11M	﹤0.01%	1064
2015 Q2	–	Sell	-116,829	Closed	-$3.66M	–	1439
2015 Q1	$3.66M	Buy	+116,829	New	+$3.39M	﹤0.01%	932

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

American Century Companies's AERI Position: Q1 2020 in Review

American Century Companies sold out of Aerie Pharmaceuticals (AERI) in Q1 2020, closing a stake of 144,877 shares — an estimated $3.5M sold.

American Century Companies first reported a position in AERI in Q1 2015 and held it in 15 quarters. The position peaked at $4.87M in Q2 2018. 155 funds tracked by Wall St. Rank hold AERI as of Q1 2020.

American Century Companies reported no remaining Aerie Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
American Century Companies sold 144,877 Aerie Pharmaceuticals shares in Q1 2020, an estimated $3.5M.
American Century Companies first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 15 quarters.
American Century Companies's Aerie Pharmaceuticals position peaked at $4.87M in Q2 2018.
155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2020.

Based on American Century Companies's 13F filing for Q1 2020, filed 14 May 2020.